Search results
Japan has an excess sushi problem. These food waste activists put it in numbers
BBC News· 6 days agoRiko Morinaga, a recent high school graduate in Tokyo, normally spends her weekend nights hanging...
Microbot partners with Boston Hospital to trial Liberty surgical robot
Medical Device Network via Yahoo Finance· 3 days agoMicrobot has completed a site initiation visit at the centre and has trained staff on the clinical...
Thinking about furthering your education this summer? 3 factors to consider
Char-Koosta News· 17 hours agoClick here to view this image from charkoosta.com.
Council Post: Are Your SaaS Integrations Secure?
Forbes· 16 hours agoSarath Babu Yalavarthi is an AVP of Product Management & Development at AT&T and a Salesforce CTA. Integrations are key to exchanging data between...
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 27,...
Tehachapi News· 3 days agoAethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced that it will issue ...
Microsoft introduces TypeScript 5.5: Explore the latest features and enhancements
Neowin· 4 days agoMicrosoft has launched TypeScript 5.5 with quite a lot of new features which you can find out more...
Micro Medical Solutions Achieves Milestone with 200th Enrollment in HEAL Registry
Morningstar· 6 days agoMicro Medical Solutions -- Micro Medical Solutions, a leader in providing innovative medical device solutions, is excited to announce that it has achieved a major milestone with the enrollment ...
Gateway - Quartz
Quartz· 6 days agoThe brain implants that Elon Musk’s Neuralink are studying in humans have been controversial, and another voice is questioning whether there should be human trials happening at all. Rep. Earl ...
Breakthrough brain recording device receives FDA approval for a clinical trial
Medical Xpress· 5 days agoThe Federal Drug Administration has approved a clinical trial to test the effectiveness of an...
Allogene Therapeutics Initiates Pivotal Phase 2 Trial Investigating Cemacabtagene Ansegedleucel...
Morningstar· 4 days agoALPHA3 Trial Has the Potential to Position Cema-cel as Part of First Line (1L) Treatment for LBCL to Improve Cure RatesFirst Prospective Trial to Incorporate the Foresight Diagnostics’s Investigational CLARITY™ Test to Identify Patients with LBCL Who